Carprieve® Injection

(carprofen)

The industry's first FDA-approved generic equivalent to Rimadyl® (carprofen) injectable. Carprieve® Injection is indicated for the relief of pain and inflammation associated with osteoarthritis (OA) and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. 

Target Species: Dogs

Product Attributes

  • Same active ingredient, formulation and dosing regimen as Rimadyl® (carprofen) Injectable

  • Compare Carprieve® Injection 50 mL versus Rimadyl® 20 mL pricing for significant savings per treatment and improved clinic profit potential

  •  Each mL of injectable solution contains 50 mg of carprofen

  •  Available in both 20 mL and economical 50 mL bottles

  •  Longer broaching period means less waste. Carprieve® Injection may be used within 56 days after its first puncture. This is twice as long as leading brands such as Rimadyl® Injectable (Zoetis) and Carprodyl® (carprofen) 50 mg/mL Injection (Ceva) which both must be used within 28 days once broached

Observe label directions. For subcutaneous use in dogs only. Do not use in cats. As with other NSAIDs, rare but serious side effects involving the digestive system, kidneys or liver may occur. Such signs may be serious, resulting in hospitalization or even death. Regular monitoring is required for pets on medication. Pet owners should be advised to discontinue use if side effects occur and contact their veterinarian. See product labeling for full product information.

  • Active Ingredient(s)

    carprofen

  • Dosage Form

    Injectable solution

  • Indications

    Carprieve Injection is indicated for the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.

  • Dosage and Administration

    Carefully consider the potential benefits and risks of carprofen and other treatment options before deciding to use Carprieve® injection. Use the lowest effective dose for the shortest duration consistent with individual response. The recommended dosage for subcutaneous administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as either 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For control of postoperative pain, administer approximately 2 hours before the procedure. 

    Carprieve Injection Dosing Chart

  • Storage

    Store under refrigeration at 36° to 46°F (2° to 8°C). Once broached, product may be stored at temperatures up to 77°F (25°C). Use within 56 days of first puncture.

© 2023 Norbrook Laboratories Limited. The Norbrook logo and Carprieve are registered trademarks of Norbrook Laboratories Limited. Rimadyl is a registered trademark of Zoetis, Inc. Carprodyl® is a registered trademark of Ceva Sante Animale SA.

Prefer to speak directly to a member of our team?

Norbrook®, Inc.

We are open Mon - Fri 8:00am - 5:00pm CST

Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.